Procter & Gamble Health Ltd. - Research Center
500126 PGHL Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Jun ' 23 | Jun ' 22 | Jun ' 21 | Jun ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 1,229.62 | 1,114.41 | 1,008.73 | 1,355.86 | 1,154.70 |
| Operating profit | 323.95 | 267.68 | 246.02 | 315.41 | 262.32 |
| Interest | 0.77 | 0.42 | 0.80 | 29.45 | - |
| Gross profit | 341.57 | 280.45 | 263.32 | 354.85 | 320.53 |
| EPS (Rs) | 138.23 | 115.98 | 106.51 | 153.06 | 123.63 |
Annual
results in details
| Jun ' 23 | Jun ' 22 | Jun ' 21 | Jun ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 18.39 | 13.19 | 18.10 | 68.89 | 58.21 |
| Stock adjustment | 2.85 | -4.75 | 4.54 | -13.03 | -9.52 |
| Raw material | 319.23 | 323.72 | 289.12 | 416.10 | 363.33 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 206.17 | 167.56 | 153.61 | 182.93 | 147.36 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 377.42 | 359.47 | 315.45 | 454.45 | 391.21 |
| Provisions made | - | 0.73 | - | - | - |
| Depreciation | 27.37 | 27.08 | 30.04 | - | 21.40 |
| Taxation | 84.73 | 60.85 | 56.48 | 100.77 | 93.90 |
| Net profit / loss | 229.47 | 192.52 | 176.80 | 254.08 | 205.22 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 26.35 | 24.02 | 24.39 | 23.26 | 22.72 |
| GPM (%) | 27.37 | 24.87 | 25.64 | 24.91 | 26.43 |
| NPM (%) | 18.39 | 17.07 | 17.22 | 17.83 | 16.92 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis